Alterity Therapeutics Limited ATHE
Set alert
2.09 USD -0.09 -4.13%
At close · Nov 2
2.12 +0.03 +1.44%
After hours · Nov 2, 4:00 PM ET
2.09 Day range 2.24
2.01 52-week range 5.89
- YTD
- -32.14%
- 1 year
- -50.36%
- Open
- 2.17
- Prev close
- 2.18
- Mkt cap
- 39.90M
- Vol
- 5.72K
- Avg vol
- 20.46K
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.09
- High
- 2.24
- Forward P/E
- -27.22
- Beta
- 0.68
- Short ratio
- 0.04
- Inst. own
- 1.28%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.48
- 200-d avg
- 1.67
- 1y target
- 8.00
3M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 3 days ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
Financial health
Altman Z-Score
1.31 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -5.9×
FY 2017 5y median -2.8× FY 2026
P/S 0.0×
FY 2017 5y median 4.3× FY 2026
P/B 3.2×
FY 2017 5y median 1.2× FY 2026
P/FCF 0.0×
FY 2017 5y median -1.3× FY 2026
EV/EBITDA -3.6×
FY 2017 5y median -0.2× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.4× FY 2026
FCF Yield 0.0%
FY 2017 5y median -35.1% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 92.9% FY 2026
Operating Margin 0.0%
FY 2017 5y median -302.6% FY 2026
Net Margin 0.0%
FY 2017 5y median -250.7% FY 2026
ROE -53.6%
FY 2017 5y median -53.6% FY 2026
ROIC -56.3%
FY 2017 5y median -56.3% FY 2026
ROA -49.7%
FY 2017 5y median -49.7% FY 2026
Growth (YoY)
Revenue -100.0%
FY 2017 FY 2026
Operating Income -90.7%
FY 2017 FY 2026
EPS (diluted) -15.8%
FY 2017 FY 2026
Free Cash Flow 100.0%
FY 2017 FY 2026
Financial Health
Current Ratio 14.5×
FY 2017 5y median 7.1× FY 2026
Quick Ratio 14.5×
FY 2017 5y median 7.1× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.3×
FY 2017 5y median 1.3× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30
